AU Patent

AU2017260532B2 — Methods and devices for preparation of ultrasound contrast agents

Assigned to Lantheus Medical Imaging Inc · Expires 2024-08-22 · 2y expired

What this patent protects

Provided herein are methods and devices for identifying and/or distinguishing UCA formulations and specifically activating such formulations to produce UCA suitable for in vivo use.

USPTO Abstract

Provided herein are methods and devices for identifying and/or distinguishing UCA formulations and specifically activating such formulations to produce UCA suitable for in vivo use.

Drugs covered by this patent

Patent Metadata

Patent number
AU2017260532B2
Jurisdiction
AU
Classification
—
Expires
2024-08-22
Drug substance claim
No
Drug product claim
No
Assignee
Lantheus Medical Imaging Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.